Published in Blood Weekly, March 9th, 1998
The high cost of existing differentiation assays and cross-reactivity makes the serologic distinction between HIV-1 and HIV-2 difficult, noted John N. Nkengasong, Project RETRO-CI, Abidjan, Ivory Coast, and colleagues.
Nkengasong et al. evaluated a strategy, based on a combination of monospecific enzyme-linked immunosorbent assays (CME) to determine its accuracy and cost-effectiveness.
They used a large panel of sera, obtained from individuals living in Abidjan, Ivory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.